|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, July 03, 2017 ) According to Publisher, the Global Active Pharmaceutical Ingredients market is expected to grow from $129.12 billion in 2015 to reach $198.8 billion by 2022 with a CAGR of 6.4%. Patent expiration of prominent drugs, government initiatives, regional penetration and increasing aged population are some of the factors that are driving the market growth. Strict validation and safety guidelines stated by WHO and fragmented market are the factors that are hampering the API market growth.
Generic/Non- Branded segment witnessed the largest market share during the forecast period due to rising healthcare costs, government prominence on generics for dropping healthcare costs, and decreasing pipelines of global pharmaceutical products. Asia Pacific is expected to be highest market share during the forecast period due to low operation costs and high investments in medical research. Moreover, the high cost of skilled labour and energy are the most significant factors that enforced European market to move its base to developing countries, such as India and China.
For more information @ http://www.reportsweb.com/active-pharmaceutical-ingredients-global-market-outlook-2016-2022
Some of the key players in global Active Pharmaceutical Ingredients market include Bioniche Animal Health (Canada), Boehringer Ingelheim (Germany), Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Limited, Bayer Healthcare (Germany), Merial Inc. (Sanofi) (France), Elanco Animal Health (U.S.), Merck Animal Health (U.S.), Ceva Animal Health, Inc., Dr. Reddy's Laboratories Ltd., Novartis International AG, Ranbaxy Laboratories, Virbac, Zoetis (U.S.), Pfizer, Inc, Aurobindo Pharma Ltd., and Heska Co. (U.S.)
Types of API Covered:
- Synthetic chemical API
o Branded/ Innovative
o Generic/Non- Branded
- Biological API
o Biotech
o Biosimilar
- High potency active pharmaceutical ingredients(HPAPI)
Types of Manufacturing Covered:
- Captive (or in-house) manufacturing
- Contract manufacturing
Therapeutic Applications Covered:
- Anti-Infectives
- Cardiovascular and hematopoietic system
- CNS and Neurological Disorders
- Diabetes
- Endocrinology
- Gastrointestinal disorder
- Hormonal-related disorder
- Metabolic disorder
- Musculoskeletal disorder
- Nephrology
- Oncology
- Ophthalmology
- Orthopedic Disorders
- Pulmonology
Request Sample Copy http://www.reportsweb.com/inquiry&RW0001583393/sample
Regions Covered:
- North America
o US
o Canada
o Mexico
- Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
- Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
- Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt
10 Company Profiling
10.1 Bioniche Animal Health (Canada)
10.2 Boehringer Ingelheim (Germany)
10.3 Sun Pharmaceutical Industries Ltd.
10.4 Teva Pharmaceutical Industries Limited
10.5 Bayer Healthcare (Germany)
10.6 Merial Inc. (Sanofi) (France)
10.7 Elanco Animal Health (U.S.)
10.8 Merck Animal Health (U.S.)
10.9 Ceva Animal Health, Inc.
10.10 Dr. Reddy's Laboratories Ltd.
10.11 Novartis International AG
10.12 Ranbaxy Laboratories
10.13 Virbac
10.14 Zoetis (U.S.)
10.15 Pfizer, Inc
10.16 Aurobindo Pharma Ltd.
10.17 Heska Co. (U.S.)
Make an enquiry: http://www.reportsweb.com/inquiry&RW0001583393/buying
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
